Law firms target Spectrum over lung cancer trial statements

The shiver of sharks circling Spectrum Pharmaceuticals is growing bigger and bigger. Another law firm joined the pack Tuesday, filing a class-action suit that accused the biotech of misrepresenting clinical trial data and failing to enroll patients in a confirmatory phase 3 study.